Deutsche Bank AG Purchases 26,425 Shares of Medidata Solutions Inc (MDSO)

Deutsche Bank AG grew its position in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 10.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 278,714 shares of the company’s stock after purchasing an additional 26,425 shares during the quarter. Deutsche Bank AG’s holdings in Medidata Solutions were worth $17,659,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Clearbridge Investments LLC increased its holdings in shares of Medidata Solutions by 0.4% during the 4th quarter. Clearbridge Investments LLC now owns 2,171,755 shares of the company’s stock valued at $137,624,000 after purchasing an additional 9,425 shares in the last quarter. Champlain Investment Partners LLC increased its holdings in shares of Medidata Solutions by 9.6% during the 4th quarter. Champlain Investment Partners LLC now owns 1,856,985 shares of the company’s stock valued at $117,677,000 after purchasing an additional 163,045 shares in the last quarter. American Century Companies Inc. increased its holdings in shares of Medidata Solutions by 21.3% during the 4th quarter. American Century Companies Inc. now owns 1,439,710 shares of the company’s stock valued at $91,234,000 after purchasing an additional 252,867 shares in the last quarter. Global Thematic Partners LLC increased its holdings in shares of Medidata Solutions by 37.3% during the 4th quarter. Global Thematic Partners LLC now owns 1,429,138 shares of the company’s stock valued at $90,564,000 after purchasing an additional 388,608 shares in the last quarter. Finally, Eagle Asset Management Inc. increased its holdings in shares of Medidata Solutions by 5.3% during the 4th quarter. Eagle Asset Management Inc. now owns 879,750 shares of the company’s stock valued at $55,877,000 after purchasing an additional 44,464 shares in the last quarter. 97.52% of the stock is owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

In other Medidata Solutions news, CEO Tarek Sherif sold 26,836 shares of Medidata Solutions stock in a transaction on Monday, March 12th. The shares were sold at an average price of $70.25, for a total transaction of $1,885,229.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Rouven Bergmann sold 2,000 shares of Medidata Solutions stock in a transaction on Monday, March 19th. The stock was sold at an average price of $66.30, for a total transaction of $132,600.00. Following the sale, the chief financial officer now directly owns 94,744 shares in the company, valued at approximately $6,281,527.20. The disclosure for this sale can be found here. Insiders sold a total of 35,836 shares of company stock worth $2,495,689 in the last three months. 5.80% of the stock is owned by corporate insiders.

Shares of Medidata Solutions Inc (MDSO) opened at $63.76 on Monday. Medidata Solutions Inc has a one year low of $54.91 and a one year high of $85.92. The stock has a market cap of $3,776.70, a price-to-earnings ratio of 86.16, a P/E/G ratio of 3.35 and a beta of 1.56. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.19.

Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings results on Thursday, February 8th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.10. Medidata Solutions had a net margin of 8.14% and a return on equity of 11.59%. The firm had revenue of $141.20 million for the quarter, compared to analysts’ expectations of $140.65 million. During the same quarter last year, the company earned $0.33 EPS. The firm’s revenue for the quarter was up 13.4% compared to the same quarter last year. equities analysts expect that Medidata Solutions Inc will post 0.93 earnings per share for the current fiscal year.

Several research firms have recently weighed in on MDSO. Royal Bank of Canada set a $82.00 target price on shares of Medidata Solutions and gave the company a “hold” rating in a report on Thursday, February 8th. TheStreet raised shares of Medidata Solutions from a “c+” rating to a “b-” rating in a report on Monday, March 12th. ValuEngine lowered shares of Medidata Solutions from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. Wells Fargo raised shares of Medidata Solutions from a “market perform” rating to an “outperform” rating and set a $80.00 target price for the company in a report on Friday, December 1st. Finally, Zacks Investment Research raised shares of Medidata Solutions from a “hold” rating to a “buy” rating and set a $70.00 target price for the company in a report on Wednesday, February 14th. One analyst has rated the stock with a sell rating, four have given a hold rating and eleven have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $82.07.

COPYRIGHT VIOLATION WARNING: This story was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://www.tickerreport.com/banking-finance/3301361/deutsche-bank-ag-purchases-26425-shares-of-medidata-solutions-inc-mdso.html.

Medidata Solutions Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

PDF Solutions  Cut to Strong Sell at ValuEngine
PDF Solutions Cut to Strong Sell at ValuEngine
Home BancShares  Rating Increased to Outperform at FIG Partners
Home BancShares Rating Increased to Outperform at FIG Partners
Two Sigma Advisers LP Has $343,000 Holdings in Versartis
Two Sigma Advisers LP Has $343,000 Holdings in Versartis
18,574 Shares in Presidio  Purchased by Two Sigma Advisers LP
18,574 Shares in Presidio Purchased by Two Sigma Advisers LP
CVS Health  Shares Bought by Valley National Advisers Inc.
CVS Health Shares Bought by Valley National Advisers Inc.
Two Sigma Advisers LP Takes Position in Acxiom Co.
Two Sigma Advisers LP Takes Position in Acxiom Co.


© 2006-2018 Ticker Report. Google+.